Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

42.46
+2.426.04%
Volume:469.80K
Turnover:19.52M
Market Cap:4.09B
PE:-21.71
High:42.56
Open:40.51
Low:40.06
Close:40.04
52wk High:42.56
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.75
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.41
PE(LYR):-33.04

Loading ...

IDEAYA Biosciences grants inducement stock options for 237,800 shares at $29.1 each

Reuters
·
May 01

IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 01

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Butterfly Network (BFLY), IDEAYA Biosciences (IDYA) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Apr 30

Ideaya Biosciences announces darovasertib combination NDA to be reviewed by FDA

TIPRANKS
·
Apr 30

IDEAYA Biosciences: to Initiate Nda Submission From Darovasertib Optimum-02 Trial

THOMSON REUTERS
·
Apr 30

IDEAYA Biosciences Inc - to Initiate Rtor Submission in May, Nda Filing Completion Expected in H2 2026

THOMSON REUTERS
·
Apr 30

FDA agrees to review IDEAYA darovasertib-crizotinib NDA under RTOR program

Reuters
·
Apr 30

IDEAYA Biosciences announces annual shareholder meeting

Reuters
·
Apr 30

IDEAYA And AstraZeneca Collaboration Adds New Dimension To IDE849 And Valuation

Simply Wall St.
·
Apr 22

IDEAYA to present complete OptimUM-02 darovasertib-crizotinib trial data at ASCO 2026

Reuters
·
Apr 21

IDEAYA Biosciences Inc : JP Morgan Raises Target Price to $81 From $78

THOMSON REUTERS
·
Apr 15

IDEAYA Biosciences Inc : Stephens Raises Target Price to $48 From $45

THOMSON REUTERS
·
Apr 15

Ideaya Biosciences Stock Not Fully Reflecting Phase 2/3 Data From Metastatic Uveal Melanoma Study, RBC Says

MT Newswires Live
·
Apr 14

IDEAYA Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 14

Ideaya Biosciences price target raised to $54 from $50 at Guggenheim

TIPRANKS
·
Apr 14

IDEAYA Biosciences Inc : Truist Securities Raises Target Price to $65 From $60

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences, Inc. : Wells Fargo Raises Target Price to $48 From $44

THOMSON REUTERS
·
Apr 14

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

IDEAYA Biosciences Inc : Leerink Partners Raises Target Price to $37 From $34

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences Inc : Guggenheim Raises Target Price to $54 From $50

THOMSON REUTERS
·
Apr 14